Ambient fine particulate matter (PM2.5) is a Group 1 carcinogen for lung cancer. Yet, as a mixture of various chemical components, the relative toxicity of its components and impacts on mortality after lung cancer diagnosis remain unclear. We conducted a cohort study of 528,127 adults aged ≥65 years with lung cancer diagnosed between 2000–2019, derived from the SEER-Medicare database. Patients were followed annually from diagnosis until death, loss to follow-up, or the end of 2019. Annual exposures to 15 PM2.5 chemical components were estimated using high-resolution spatiotemporal models and linked to each patient based on residential ZIP code in each year. We used generalized weighted quantile sum regression to estimate the joint effect of exposure to all components and their individual contributions, adjusted for demographics, histological type, stage, first-course treatments, comorbidities, and neighborhood-level covariates. We found that joint exposure to PM2.5 components was associated with increased mortality, with relative risk (RR) being 1.012 (95% confidence interval [CI], 1.011–1.014) per decile increase in all components. Iron contributed most strongly (8.3% of total effects), with similar contributions by organic carbon, vanadium, ammonium, bromine, and silicon. Associations were stronger among patients with non-small cell lung cancer, women, and those with regional stage lung cancer. Overall, our findings suggest the need to protect older lung cancer patients, who face poor prognosis after diagnosis, from air pollution, particularly for the susceptible subgroups. The components contributing most to risk also suggest the importance of targeted emission reductions from traffic, biomass burning, and industrial combustion.